| ID: | 66 | |
|---|---|---|
| Name: | Compound 66 | |
| Description: | Original numeration in publication: 11e | |
| Labels: | Training_set, Quinoxalines | |
| CAS: | ||
| InChi Code: | InChI=1S/C26H23N5O4/c1-16(29-30-25(34)20-7-3-6-10-23(20)32)18-11-13-19(14-12-18)28-24(33)15-31-22-9-5-4-8-21(22)27-17(2)26(31)35/h3-14,32H,15H2,1-2H3,(H,28,33)(H,30,34)/b29-16+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 5.99 |
El-Adl, K.; Sakr, H. M.; Yousef, R. G.; Mehany, A. B. M.; Abulkhair, H. S.; Eissa, I. H. New quinoxalin-2(1H)-one-derived VEGFR-2 inhibitors: Design, synthesis, in vitro anticancer evaluations, in silico ADMET, and docking studies. Arch. Pharm. (Weinheim) 2022, 355, e2200048. https://doi.org//10.1002/ardp.202200048 |
| 7.06967 |
Eq1: VEGFR-2 inhibition (Data used to train model) |